CMPX vs DKNG · $367.4M cap vs rev $4.77B
Compass Therapeutics Inc. (CMPX) versus DraftKings Inc (DKNG) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
DraftKings Inc (DKNG) is a gambling company listed on US.
CMPX does not have a complete income-statement cache yet.
Latest reported DKNG revenue for 2024-12-31 was $4.77B. Net income was -$507.3M. Revenue was up 30.1% from 2023-12-31 to 2024-12-31. DKNG currently screens at market cap $20.96B.
CMPX currently screens at market cap $367.4M. DKNG currently screens at market cap $20.96B.
Not investment advice. Open the CMPX and DKNG stock pages for the full models.
Not investment advice.